Von Hippel-Lindau disease and central nervous system hemangioblastomas: Progress in genetics and clinical management;Maladie de Von Hippel-Lindau et hemangioblastomes du systeme nerveux central: Applications cliniques des progres genetiques

Neurochirurgie

Volumn 44, Issue 4, 1998, Pages 258-266

  Richard, S ^a   Martin, S ^b   David, Ph ^c   Decq, Ph ^d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BICÊTRE HOSPITAL   (France)

^c CHU de Nantes   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Genetics; Hemangioblastoma; Von Hippel Lindau disease

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 3P; ENDOLYMPHATIC SAC; GENE EXPRESSION REGULATION; GENE MUTATION; HEMANGIOBLASTOMA; HUMAN; KIDNEY CARCINOMA; KIDNEY CYST; VON HIPPEL LINDAU DISEASE;

CENTRAL NERVOUS SYSTEM NEOPLASMS; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HEMANGIOBLASTOMA; HIPPEL-LINDAU DISEASE; HUMANS; INCIDENCE;

EID: 0031731434     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. BAILLY M, BAIN C, FAVROT MC, OZTURK M. Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancer. Int J Cancer 1995 ; 63 : 660-664.
2. BOUGHEY AM, FLETCHER NA, HARDING AE. Central nervous system hemangioblastoma : a clinical and genetic study of 52 cases. J Neurol Neurosurg Psychiatr 1990 ; 53 : 644-648.
3. BRAUCH H, KISHIDA T, GLAVAC D, CHEN F, PAUSCH F, HOFLER H, LATIF F, LERMAN M, ZBAR B, NEUMANN HPH. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany : evidence for a founder effect. Hum Genet 1995; 95 : 551-556.
4. CHAUVEAU D, DUVIC C, CHRÉTIEN Y, PARAF F, DROZ D, MELKI P, HÉLÉNON O, RICHARD S, GRUNFELD JP. Renal involvement in von Hippel-Lindau disease. Kidney Int 1996 ; 50 : 944-951.
5. CHOYKE PL, GLENN GM, WAGNER JP, LUBENSKY IA, THAKORE K, ZBAR B, LINEHAN WM, WALTHER McM. Epididymal cystadenomas in von Hippel-Lindau disease. Urology 1997 ; 49 : 926-931.
6. CHRÉTIEN Y, CHAUVEAU D, RICHARD S, DROZ D, CORRÉAS JM, MÉJEAN A, DUFOUR B, GRÜNFELD JP. Traitement de la maladie de von Hippel-Lindau avec atteinte rénale. Prog Urol 1997 ; in press.
7. DUAN DR, PAUSE A, BURGESS WH, Aso T, CHEN DYT, GARRETT KP, CONAWAY RC, CONAWAY JW, LINEHAN WM, KLAUSNER RD. Inhibition of transcription elongation by the VHL tumor suppressor protein Science 1995 ; 269 : 1402-1406.
8. FILLING-KATZ MR, CHOYKE PL, OLDFIELD E, CHARNAS L, PATRONAS NJ, GLENN GM, GORIN M, MORGAN J, LINEHAN W, SEIZINGER B. Central nervous system involvement in von Hippel-Lindau disease. Neurology 1991 ; 41 : 41-6.
9. GNARRA JR, TORY K, WENG Y, SCHMIDT L, WEI MH, LI H, LATIF F, LIU S, CHEN F, DUH FM, LUBENSKY I, DUAN DR, FLORENCE C, POZZATTI R, WALTHER MM, BANDER NH, GROSSMANN HB, BRAUCH H, PORNER S, BROOKS JD, ISAAC WB, LERMAN MI, ZBAR B, LINEMAN WM. Mutations of the VHL tumor suppressor gene in renal cell carcinoma. Nature Genet 1994 ; 7 : 85-89.
10. GNARRA JR, ZHOU S, MERRILL MJ, WAGNER JR, KRUMM A, PAPAVASSILIOU E, OLDFIELD EH, KLAUSNER RD, LINEHAN WM. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 1996 ; 93 : 10589-10594.
11. GNARRA JR, WARD JM, PORTER FD, WAGNER JR, DEVOR DE, GRINBERG A, EMMERT-BUCK MR, WESTPHAL H, KLAUSNER RD, LINEMAN WM. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 1997; 94: 9102-9107.
12. HAMMEL P, BEIGELMAN C, CHAUVEAU D, RESCHE F, BOUGEROLLES E, FLÉJOU JF, BERNADES P, DELCHIER JC, RICHARD S. Variété des lésions pancréatiques au cours de la maladie de von Hippel-Lindau. Gastroenterol Clin Biol 1995 ; 19 : 1011-1017.
13. HATVA E, BOHLING T, JAASKELÄIEN J, PERSICO MG, HALTIA M, ALITALO K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 1996 ; 148 : 763-775.
14. HERMAN JG, LATIF F, WENG Y, LERMAN MI, ZBAR B, LIU S, SAMID D, DUAN DR, GNARRA JR, LINEHAN WM, BAYLIN SB. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal cell carcinoma. Proc Natl Acad Sci USA 1995 ; 91 : 9700-9704.
15. HURTH M, ANDRÉ JM, DJINDJIAN R, ESCOUROLLE R, HOUDART R, POIRIER J, REY A. Les hémangioblastomes intra-rachidiens. Neurochirurgie 1915 ; 21S : 1-136.
16. ILIOPOULOS O, KIBEL A, GRAY S, KAELIN WG. Tumor suppression by the human von Hippel-Lindau gene product. Nature Med 1995 ; 1 : 822-826.
17. ILIOPOULOS O, LEVY AP, JIANG C, KAELIN WG, GOLDBERG MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 1996 ; 93 : 10595-10599.
18. KANNO H, KONDO K, ITO S, YAMAMOTO I, FUJII S, TORIGOE T, SAKAI N, HOSAKA M, SHUIN T, YAO M. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastoma. Cancer Res 1994 ; 54 : 4845-4847.
19. KEMPERMANN G, NEUMANN HPH, SCHEREMET R, VOLCK B, MANN W, GILSBACH J, LASZIG R. Deafness due to bilateral endolymphatic sac tumors in a case of von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatr 1996 ; 61 : 318-320.
20. KIBEL A, ILIOPOULOS O, DECAPRIO JA, KAELIN WG. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 1995 ; 269 : 1444-1446.
21. LAMIELL JM, SALAZAR FG, HSIA YE. Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 1989 ; 68 : 1-29.
22. LATIF F, TORY K, GNARRA J, YAO M, DUH FM, ORCUTT ML, STACKOUSE T, KUZMIN I, MODI W, GEIL L, SCHMIDT L, ZHOU F, LI H, WEI MH, CHEN F, GLENN G, CHOYKE P, WALTHER MM, WENG Y, DUAN DR, DEAN A, GLAVAC D, RICHARDS FM, CROSSEY PA, FERGUSON-SMITH MA, LE PASLIER D, CHUMAKOV I, COHEN D, CHINAULT CA, MAKER ER, LINEHAN WM, ZBAR B. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993 ; 260 : 1317-1320.
23. LEE S, CHEN DYT, HUMPHREY JS, GNARRA JR, LINEMAN WM, KLAUSNER RD. Nuclear/cytoplasmic localization of th von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci USA 1996 ; 93 : 1770-1775.
24. LEVY AP, LEVY NS, GOLDBERG MA. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biom Chem 1996 ; 271 : 25492-25497.
25. LINDAU A. Studien über Kleinhirnzysten. Bau. Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Pathol Microbiol Scand 1926 ; S1 : 1-128.
26. LINEHAN WM, LERMAN MI, ZBAR B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 1995 ; 273 : 564-570.
27. LOS M, JANSEN GH, KAELIN WG, LIPS CJM, BLIJHAM GHB, VOEST EE. Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest 1996 ; 75 : 231-238.
28. LUBENSKY IA, GNARRA JR, BERTHEAU P, WALTHER MMc, LINEHAN WM, ZHUANG Z. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 1996 ; 149 : 2089-2094.
29. MADDOCK IR, MORAN A, MAHER ER, TEARE MD, NORMAN A, PAYNE SJ, WHITEHOUSE R, DODD A, LAVIN M, HARTLEY N, SUPER M, EVANS DG. A genetic register for von Hippel-Lindau disease. J Med Genet 1996 ; 33 : 120-127.
30. MAKER ER, KAELIN W. Von Hippel-Lindau disease. Molecular review. Medicine 1997 ; 76 : 381-391.
31. MAHER ER, YATES JRW, FERGUSON-SMITH MA. Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J Med Genet 1990 ; 27 : 311-314.
32. MAHER ER, YATES JRW, HARRIES R, BENJAMIN C, HARRIS R, MOORE AT, FERGUSON-SMITH MA. Clinical features and natural history of Von Hippel-Lindau disease. Q J Med 1990 ; 77 : 1151-1156.
33. MANSKI TJ, HEFFNER DK, GLENN GM, PATRONAS N, PIKUS A, KATZ D, LEBOVICS R, SLEDJESKI K, CHOYKE P, ZBAR B, LINEHAN W, OLDFIELD E. Endolymphatic sac tumors. A source of hearing loss in von Hippel-Lindau disease. JAMA 1997 ; 277 : 1461-1466.
34. NEUMANN HPH, EGGERT HR, SCHEREMET R, SCHUMACHER M, MOHADJER M, WAKHLOO AK, VOLK B, HETTMANNS-PERGER U, RIEGLER P, SCHOLLMEYER P, WIESTLER O. Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatr 1992 ; 55 : 898-901.
35. NEUMAN HPH, BERGER DP, SIGMUND G, BLUM U, SCHMIDT D, PARMER RJ, VOLK B, KIRSTE G. Pheochromocytomas, multiple endocrine neoplasia type 2. and von Hippel-Lindau disease. N Engl J Med 1993 ; 329 : 1531-1358.
36. NEUMANN HPH, ENG C, MULLIGAN L, GLAVAC D, PONDER B, CROSSEY P, MAHER E, BRAUCH H. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia type 2. JAMA 1995 ; 274 : 1149-1151.
37. NEUMAN HPH, BENDER BU, JANUSZEWICZ A, JANETSCHEK G, ENG C. Phéochromocytome familial. In : Grünfeld JP, BACH JF, KREIS H, eds. Actualités néphrologiques Jean Hamburger, Paris : Médecine-Sciences Flammarion, 1997 : 337-350.
38. NIEMELA M, LIM YJ, SODERMAN M, JAÄSKELAINÄINEN J, LIVDQUIST C. Gamma knife radiosurgery in 11 hemangioblastoma. J Neurosurg 1996 ; 85 : 591-596.
39. OBERSTRASS J, REIFENBERGER G, WECHSLER W, COLLINS VP. Mutation of the von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system. J Pathol 1996 ; 179 : 151-156.
40. OLSCHWANG S, RICHARD S, BOISSON C, RESCHE F, THOMAS G. DNA-based presymptomatic diagnosis for the von Hippel-Lindau disease by linkage analysis. Eur J Hum Genet 1995 ; 3 : 108-115.
41. OLSCHWANG S, RICHARD S, BOISSON C, GIRAUD S, LAURENT-PUIG P, RESCHE F, THOMAS G. Germline mutations profiles of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastomas. Hum Mutat, in press.
42. OUALLET JC, MARSOT-DUPUCH K, VAN EFFENTERRE R, KUJAS M, TUBIANA JM. Papillary adenoma of endolymphatic sac origin : a temporal bone tumor in von Hippel-Lindau disease. J Neurosurg 1997 ; 87 : 445-449.
43. PROWSE A, WEBSTER AR, RICHARDS FM, RICHARD S, OLSCHWANG S, RESCHE F, AFFARA NA, MAHER ER. Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumours. Am J Hum Genet 1997 ; 60 : 765-771.
44. RESCHE F, CHABANNES J, COMBELLES G, DJINDJIAN M, FISCHER G, HASSOUN J, HURTH M, DE KERSAINT-GILLY A, RAVON R. Les hémangioblastomes infratentoriels. Neurochirurgie 1985 ; 31 : 91-149.
45. RESCHE F, MOISAN JP, MANTOURA J, DE KERSAINT-GILLY A, ANDRÉ MJ, PERRIN-RESCHE I, MENEGALLI-BOGELLI D, LAJAT Y, RICHARD S. Hemangioblastomas, hemangioblastomatosis and von Hippel-Lindau disease. Adv Techn Stand Neurosurg 1993 ; 20 : 197-303.
46. RICHARD S, BEIGELMAN C, DUCLOS JM, FENDLER JP, PLAUCHU H, PLOUIN PF, RESCHE F, SCHLUMBERGER M, VERMESSE B, PROVE C. Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery 1994 ; 116 : 1076-1081.
47. RICHARD S, BEIGELMAN C, GERBER S, VAN EFFENTERRE R, GAUDRIC A, SAHEL M, BINAGHI M, HOUTTEVILLE JP, BRUNON JP, GUÉRIN J, CORNU P, REDONDO A, HURTH M, RESCHE F. L'hémangioblastome existe-t-il en dehors de la maladie de von Hippel-Lindau ? Neurochir 1994 ; 40 : 145-154.
48. RICHARD S, GIRAUD S, HAMMEL P, BEROUD C, JOLY D, OLSCHWANG S, RESCHE F. La maladie de von Hippel-Lindau : une maladie à impact tissulaire multiple. Presse Med 1998 : in press.
49. RICHARD S, CAMPELLO C, TAILLANDIER L, PARKER F, RESCHE F Hemangioblastomas of the central nervous system in von Hippel-Lindau disease. J Intern Med 1998 . in press.
50. RICHARDS FM, PAYNE SJ, ZBAR B, AFFARA NA, FERGUSON-SMITH MA, MAHER ER. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Molec Genet 1995 ; 4 : 2139-2143.
51. ROUQUETTE I, CERVERA P, RICHARD S, URO E, DAUMAS-DUPORT C, DELISLE MB. Adénocarcinome papillaire de bas grade du sac endolymphatique. Ann Pathol 1996 ; 16 : 271-275.
52. SIEMEISTER G, WEINDEL K, MOHRS K, BARLEON B, MATINY-BARON G, MARME D. Reversion of deregulated expression of vascular endothelial growth factor in human renal cell carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 1996; 56: 2299-2301.
53. Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. J Clin Oncol 1996 ; 14 : 1730-1736.
54. STEINBACH F, NOVICK AC, ZINCKE H, MILLER D, WILLIAMS RD, LUND G, SKINNER DG, ESRIG D, RICHIE J, DE KERNION JB, MARSHAL F, MARSH CL. Treatment of renal cell carcinoma in von Hippel-Lindau disease : a muiticentric study. J Urol 1995 ; 153 : 1812-1816.
55. TORY KH, BRAUCH H, LINEHAN M, BARBA D, OLDHELD E, FILLING-KATZ M, SEIZINGER B, NAKAMURA Y, WHITE R, MARSHALL FF, LERMAN M, ZBAR B. Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl Cancer Inst 1989 ; 87 . 1097-1101.
56. Von Hippel E. Vorstellung eines Patienten mit einer sehr ungewöhnlichen Netzhaut. XXIV Verstellung der ophtalmologischen Gesellschaft (Heidelberg, 1895). Wiesbaden JF Bergmann Verlag, 269.
57. Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol 1997; 151: 951-956.
58. WIZIGMANN-VOOS S, BREUIER G, RISAU W, PLATE KH Upregulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastoma. Cancer Res 1995; 55: 1358-1364.
59. ZBAR B, KISHIDA T, CHEN F, SCHMIDT L, LERMAN MI, MAHER E, BRAUCH H, NEUMANN H, TISCHERMAN S, MULVIHIL J, GROSS D, SHUIN T, WHALEY J, SEIZINGER B, OLSCHWANG S, BOISSON C, RICHARD S, LIPS CHM, LINEHAN WM. Germline mutations in the von Hippel-Lindau (VHL) gene in families from North America, Europe and Japan. Hum Mutat 1996; 8: 348-357.